Green Chemicals Blog
-
Vertellus files for bankruptcy
.
Indianapolis, US-based Vertellus Specialties has long been a player in the castor oil derivatives market even before it was formed in 2006 through the combined operations of Reilly Industries and Rutherford Chemicals (anybody remembers sebacic acid producer, Caschem based in New Jersey?). Vertellus recently announced that it has voluntarily filed for Chapter 11 Bankruptcy protection in…
-
Association, Company initiatives, Conference, Government, Investments, Partnership, Press Release, R&D, VideoSynthetic Biology – The next renewables frontier?
.
Ok, so the title might be a bit misleading as I’ve been covering agbiotech for more than a decade and synthetic biology companies focusing on chemicals application since 2007 such as Genomatica, Amyris, Codexis, etc. However, it seems there are more and more interests these days on genome engineering tools for chemicals production as DNA synthesis…
-
Global Bioenergies advances bio-isobutene commercialization
.
Because I like posting videos, here’s one that was just published by France-based Global Bioenergies, which is currently building its new bio-isobutene demonstration plant at Leuna, a German petrochemical/refining complex. The first run on the demo plant is expected this autumn. Global Bioenergies also recently announced a EUR 9 million funding received under the Investissements…
-
Hard times for public renewable chemical companies
.
The past year and a half (or almost two years) has been very hard for public chemical companies as Codexis and Solazyme (now Terravia) reinvented themselves, while Gevo and Metabolix shareholders seem to be now looking into selling the companies as options due to financial difficulties. Gevo just announced that it hired Cowen & Company to explore…
-
Protected: Bio-based surfactants continue to see growth opportunities
.
There is no excerpt because this is a protected post.
-
Amyris, CJ CheilJedang Partnership
.
CJ CheilJedang has definitely been very busy this year in the bio-sphere. Amyris and South Korea-based CJ CheilJedang Corporation have signed a Memorandum of Understanding (MOU) to support large-scale manufacturing of Amyris’s farnesene in existing CJ facilities. The arrangement described in the MOU would enable Amyris to utilize CJ’s manufacturing capacity while minimizing the capital…
